#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

T-cell lymphoma Fibrodysplasia ossificans progressiva Cutaneous T-cell lymphoma refractory Transferrin decreased Liposarcoma Retinal dystrophy B-cell lymphoma Uterine leiomyosarcoma Multifocal motor neuropathy Systemic sclerosis pulmonary Cold type haemolytic anaemia Skin cancer Primary adrenal insufficiency C3 glomerulopathy Extra-osseous Ewing's sarcoma More trials…
Learn about Rare Diseases

Inclusion body myositis – Trials in Disease Sjogren’s syndrome – Basic Information Rhabdoid tumour – Trials in Disease Splenic marginal zone lymphoma – Basic Information Sarcoma – Diagnostics Inclusion body myositis Bronchiolitis obliterans syndrome Antisynthetase syndrome – Basic Information KBG syndrome Anaplastic thyroid cancer – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Calcium Lactate Gluconate Teriflunomide Atuliflapon Vancomycin Hydrochloride Diphenhydramine Garadacimab R3R01 Felzartamab Salbutamol Sulfate Ph. Eur. Alxn2220 [18F]Fluoro-Peg-Folate ANOC-001 Ecoo1A Dmd06-Mab Bevacizumab Zirconium Zr-89 AZD0516 Dexamethasone Isonicotinate Tovinontrine Hct116-A Farletuzumab Ecteribulin More therapies…

Learn about Your Condition

Pleomorphic leiomyosarcoma Univentricular heart Myelodysplastic syndrome Bronchitis Vertebrobasilar stroke Pancreatitis relapsing Left ventricular dysfunction COVID-19 Osteomyelitis acute Laryngeal cancer Peptostreptococcus infection Mixed-type liposarcoma Chronic disease Cervix carcinoma stage IV Marginal zone lymphoma More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Microscopic polyangiitis

Rituximab versus clinic‑biological monitoring for ANCA reactivation in patients with GPA or MPA (with prednisolone)

Not yet recruiting

3 1 1 1
Investigated Drugs:
- Prednisolone
- Rituximab
Study of iptacopan effectiveness in achieving remission in patients with active ANCA-associated vasculitis

Not recruiting

2 1
Investigated Diseases:
- Granulomatosis with polyangiitis
- Microscopic polyangiitis
Investigated Drugs:
- Iptacopan
+3
Study on Imlifidase for Patients with Severe ANCA-Associated Vasculitis and Lung Bleeding

Not recruiting

2 1 1 1
Investigated Drugs:
- Imlifidase

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Microscopic polyangiitis

Rituximab versus clinic‑biological monitoring for ANCA reactivation in patients with GPA or MPA (with prednisolone)

Study of iptacopan effectiveness in achieving remission in patients with active ANCA-associated vasculitis

Study on Imlifidase for Patients with Severe ANCA-Associated Vasculitis and Lung Bleeding

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies